Related Experiment Videos
Phenotypic variability (heterogeneity) of peroxisomal disorders
Hanna Mandel1, Stanley H Korman
1Metabolic Disease Unit, Department of Pediatrics, Rambam Medical Center, Technion-Israel Institute of Technology, Bruce Rappaport Faculty of Medicine, Haifa, Israel. h_mandel@rambam.health.gov.il
Advances in Experimental Medicine and Biology
|January 10, 2004
Summary
Peroxisomal disorders, affecting lipid metabolism, arise from enzyme deficiencies or biogenesis defects. Biochemical assays define specific phenotypes, aiding diagnosis despite overlapping clinical features and heterogeneity.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Peroxisomes are vital organelles involved in lipid metabolism and other cellular functions.
- Peroxisomal disorders stem from defects in single enzymes/proteins or peroxisomal biogenesis.
- These disorders lead to impaired peroxisomal functions and metabolite imbalances.
Purpose of the Study:
- To highlight the diagnostic challenges in peroxisomal disorders.
- To emphasize the link between biochemical and clinical phenotypes.
- To underscore the need for a high index of suspicion in clinical diagnosis.
Main Methods:
- Utilizing a battery of biochemical assays to define peroxisomal disorder phenotypes.
- Correlating biochemical dysfunction with clinical manifestations.
- Analyzing patterns of clinical abnormalities, including neurological, craniofacial, and sensory defects.
Main Results:
- Biochemical assays establish specific, diagnostic phenotypes for peroxisomal disorders.
- Clinical phenotypes can be unique or share overlapping features (neurological, craniofacial, skeletal, sensory).
- Clinical heterogeneity and overlap between single enzyme defects and peroxisomal biogenesis disorders (PBDs) are significant.
Conclusions:
- Biochemical phenotyping is crucial for diagnosing peroxisomal disorders.
- Clinical features reflect metabolite accumulation/deficiency but show considerable heterogeneity.
- Accurate diagnosis requires recognizing the correlation between biochemical severity and clinical presentation.